Noëlle Remoué has a total of 66 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Comparative Effect of Soft, Hard and Chlorinated Water on Atopic Skin and Clinical Benefits of a Dermocosmetic Routine

    by Sandrine Bergera Virassamnaik, Helena Polena, Noëlle Remoué, Benoît Cadars, Elodie Prestat-Marquis, Elodie Valin

    Background: Epidemiological data link hard and chlorinated water to atopic dermatitis (AD), but experimental evidence on their effect and on dermocosmetic benefit remains limited. Objectives: We aimed to compare the effects of soft, hard, and chlorinated water on atopic skin and assess whether a dermocosmetic routine mitigates these effects. Methods: In a 3-day, open-label, intra-individual study, 66 adults with atopic skin underwent repeated forearm immersions (five cycles/day) in soft, hard, or chlorinated water. One forearm received a cleansing-oil and moisturising-balm routine after each cycle; the contralateral forearm served as untreated control. TEWL, hydration, and global discomfort were assessed. In a 21-day real-life study, adults with AD regularly exposed to hard domestic or swimming-pool water used the routine daily. Discomfort and quality of life were recorded. Results: Water immersion induced modest, inconsistent TEWL changes, increased hydration and slightly reduced discomfort, without differences between water types. The routine reduced TEWL, increased hydration, and decreased discomfort for all water types. In real life, it produced immediate and sustained improvements in discomfort and quality of life. Conclusions: Under controlled exposure, soft, hard, and chlorinated water exert comparable, limited effects on atopic skin. The dermocosmetic routine consistently improves barrier-related parameters and comfort, independently of water type.

  • Open Access

    Comparative Impact of Hard and Chlorinated Water on Biometrological Parameters of Atopic Skin and the Clinical Benefits of Dermocosmetic Routine Interventions

    by Sandrine Bergera Virassamnaik, Noëlle Remoué, Benoît Cadars, Elodie Prestat, Elodie Valin

    Background: Epidemiological studies have established a positive association between water hardness, chlorine content, and the prevalence or severity of atopic dermatitis (AD). These environmental factors are known to exacerbate skin barrier dysfunction and increase discomfort in individuals with atopy-prone skin. Objectives: This research aimed to objectify the detrimental effects of hard and chlorinated water on atopic skin, both under controlled experimental conditions and in real-life settings. The studies assessed the efficacy of a daily dermocosmetic routine (comprising a cleanser and moisturizer adapted for atopy-prone skin) for reducing water-induced discomfort and improving the quality of life. Methods: Three clinical studies were conducted: one experimental comparative study of repeated washing or immersion with hard, chlorinated, and soft water, and two intra-individual 21-day studies on hard water and swimming pool water (chlorinated) exposure in real-life conditions. Results: Cumulative exposure to hard water (HW) and chlorinated water (CW) increased TEWL, while soft water (SW) had no significant effect on barrier function. The dermocosmetic routine significantly improved skin hydration and barrier function, with TEWL significantly decreasing by 25% (HW), 17% (CW), and 20% (SW) compared to untreated areas. In real-life studies, 21-day use of the products significantly reduced skin discomfort and improved quality of life. Conclusion: Repeated exposure to hard and chlorinated water can exacerbate skin discomfort and clinical symptoms of atopic dermatitis. An adapted daily dermocosmetic routine can significantly mitigate these effects, improving barrier function, skin comfort, and daily quality of life.

  • Open Access

    In Vitro Sensitive Skin Models: Review of the Standard Methods and Introduction to a New Disruptive Technology

    by Alexandre Guichard, Noëlle Remoué, Thibault Honegger

    The skin is a protective organ, able to decode a wide range of tactile, thermal, or noxious stimuli. Some of the sensors belonging to the transient receptor potential (TRP) family, for example, TRPV1, can elicit capsaicin-induced heat pain or histamine-induced itching sensations. The sensory nerve fibers, whose soma is located in the trigeminal or the dorsal root ganglia, are able to carry signals from the skin’s sensory receptors toward the brain via the spinal cord. In some cases, in response to environmental factors, nerve endings might be hyper activated, leading to a sensitive skin syndrome (SSS). SSS affects about 50% of the population and is correlated with small-fiber neuropathies resulting in neuropathic pain. Thus, for cosmetical and pharmaceutical industries developing SSS treatments, the selection of relevant and predictive in vitro models is essential. In this article, we reviewed the different in vitro models developed for the assessment of skin and neuron interactions. In a second part, we presented the advantages of microfluidic devices and organ-on-chip models, with a focus on the first model we developed in this context.


  • Contributors

    by Pierre Badel, Dimitri Beeckman, Christine Thies Berke, Joyce Marie Black, Ulrike Blume-Peytavi, Kath M. Bogie, Christelle Bonod, David Brienza, M. Bucki, Evan Call, et al.

  • Development of an in vitro model of menopause using primary human dermal fibroblasts

    by N. Remoué, J. Molinari, E. Andres, J. C. Lago, C. Barrichello, P. L. Moreira

    Synopsis: Objective: To overcome the current lack of in vitro models to specifically reproduce hormonal skin ageing in women, and in search of active ingredients with innovative efficacy claim for cosmetic skin care, we developed a cell culture‐based model by simulating menopause's hormonal decline and assessed several parameters of collagen metabolism.Methods: Human dermal fibroblasts were incubated with media containing 17β‐oestradiol, progesterone, dehydroepiandrosterone, growth hormone and insulin‐like growth factor‐1 at concentrations corresponding to those of non‐menopausal women's sera and then of menopausal women's sera. We measured cell proliferation [by 3‐[4,5‐dimethylthiazol‐2‐yl]‐2,5‐diphenyltetrazolium bromide (MTT)], matrix metalloproteinase‐1 and metalloproteinase‐3 (MMPs) release (by enzyme‐linked immunosorbent assay – ELISA), total collagen deposition (by Sirius red staining), types I and III collagen deposition (by ELISA), and types I and III procollagen gene expression (by real‐time q‐RT‐PCR).Results: Our results showed a significant decrease over time in cell proliferation, collagen deposition and type III/type I collagen ratio, together with an increase in MMP release, when cells were incubated in media containing sex hormones at menopausal levels. This is consistent with in vivo data from menopausal women available in the literature. Surprisingly, procollagen gene expression was only reduced within the first hours and increased afterwards when compared with non‐menopausal culture conditions.Conclusion: Our results demonstrated that the increased procollagen synthesis with menopausal conditions was not sufficient to compensate for the MMPs' catabolic effects and/or the impaired procollagen protein maturation, resulting in a decrease in extracellular collagen content. These findings add to the overall understanding of hormone‐dependent skin behaviour and highlight the suitability of this in vitro model for cosmetic actives testing aiming to underpin claims of anti‐ageing efficacy, specifically for menopausal women, regarding collagen metabolism and balance of types, for maintenance of dermal mechanical properties.


  • Reconstructed human epidermis (RHE) use for genotoxicity testing with less false positive results

    by E. Andres, J. Molinari, N. Remoué, V.M. Sá-Rocha, S. Hurtado, C. Barrichello